Plant viral elongated nanoparticles modified for log-increases of foreign peptide immunogenicity and specific antibody detection

Journal of Biotechnology

Volumn 168, Issue 4, 2013, Pages 409-415

  Sánchez, Flora ^a   Sáez, María ^a   Lunello, Pablo ^b   Ponz, Fernando ^a  

^a ETSI MontesTechnical University of Madrid   (Spain)

^b Agrenvec   (Spain)

Author keywords

Antibody; Detection; Peptide presentation; VEGFR 3; Viral nanoparticles

Indexed keywords

ANTIBODY DETECTION; ELONGATED NANOPARTICLES; IMMUNOGENICITY; QUANTITATIVE DATA; TURNIP MOSAIC VIRUS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; VEGFR-3; VIRAL NANOPARTICLES;

AMINO ACIDS; CHEMICAL DETECTION; ERROR DETECTION; IMMUNIZATION; MAMMALS; NANOPARTICLES; PEPTIDES; PURIFICATION; VIRUSES;

ANTIBODIES;

COAT PROTEIN; PEPTIDE VACCINE; VASCULOTROPIN RECEPTOR 3;

ANIMAL EXPERIMENT; ANTIBODY DETECTION; ARABIDOPSIS THALIANA; ARTICLE; BRASSICA JUNCEA; CODON; ELECTRON MICROSCOPE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE CONSTRUCT; GENE INSERTION; IMMUNIZATION; IMMUNOGENICITY; MALE; MOSAIC VIRUS; MOUSE; NONHUMAN; PLANT VIRUS; PRIORITY JOURNAL;

MUS; TURNIP MOSAIC VIRUS;

ANTIBODY; DETECTION; PEPTIDE PRESENTATION; VEGFR-3; VIRAL NANOPARTICLES;

ANIMALS; ANTIBODIES; BRASSICA NAPUS; HUMANS; MICE; NANOPARTICLES; PEPTIDES; TYMOVIRUS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VIRION;

EID: 84888841330     PISSN: 01681656     EISSN: 18734863     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2013.09.002     Document Type: Article

References (43)

1. Andresen H., Grotzinger C. Deciphering the antibodyome - peptide arrays for serum antibody biomarker diagnostics. Curr. Proteomics 2009, 6:1-12.
2. Aoki Y., Tosato G. Lymphatic regeneration: new insights from VEGFR-3 blockade. J. Natl. Cancer Inst. 2005, 97:2-3.
3. Arazi T., Shiboleth Y.M., Gal-On A. A nonviral peptide can replace the entire N terminus of zucchini yellow mosaic potyvirus coat protein and permits viral systemic infection. J. Virol. 2001, 75:6329-6336.
4. Bulinski J.C. Peptide antibodies: new tools for cell biology. Int. Rev. Cytol. 1986, 103:281-302.
5. Calvo C.F., Fontaine R.H., Soueid J., Tammela T., Makinen T., Alfaro-Cervello C., Bonnaud F., Miguez A., Benhaim L., Xu Y., Barallobre M.J., Moutkine I., Lyytikka J., Tatlisumak T., Pytowski B., Zalc B., Richardson W., Kessaris N., Garcia-Verdugo J.M., Alitalo K., Eichmann A., Thomas J.L. Vascular endothelial growth factor receptor 3 directly regulates murine neurogenesis. Genes Dev. 2011, 25:831-844.
6. Cerovska N., Hoffmeisterova H., Pecenkova T., Moravec T., Synkova H., Plchova H., Veleminsky J. Transient expression of HPV16 E7 peptide (aa 44-60) and HPV16 L2 peptide (aa 108-120) on chimeric potyvirus-like particles using Potato virus X-based vector. Protein Expr. Purif. 2008, 58:154-161.
7. Fernández-Fernández M.R., Martínez-Torrecuadrada J.L., Casal J.I., García J.A. Development of an antigen presentation system based on plum pox potyvirus. FEBS Lett. 1998, 427:229-235.
8. Fernández-Fernández M.R., Martínez-Torrecuadrada J.L., Roncal F., Domínguez E., García J.A. Identification of immunogenic hot spots within plum pox potyvirus capsid protein for efficient antigen presentation. J. Virol. 2002, 76:12646-12653.
9. Gil F., Reytor E., Perez-Filgueira D.M., Escribano J.M. Multimerization of peptide antigens for production of stable immunogens in transgenic plants. J. Biotechnol. 2007, 128:512-518.
10. Gillitzer E., Willits D., Young M., Douglas T. Chemical modification of a viral cage for multivalent presentation. Chem. Commun. 2002, 2390-2391.
11. Grill L.K., Palmer K.E., Pogue G.P. Use of plant viruses for production of plant-derived vaccines. Crit. Rev. Plant Sci. 2005, 24:309-323.
12. Hancock D.C., O'Reilly N.J. Synthetic peptides as antigens for antibody production. Methods Mol. Biol. 2005, 295:13-26.
13. Jennings G.T., Bachmann M.F. Immunodrugs: therapeutic VLP-based vaccines for chronic diseases. Annu. Rev. Pharmacol. Toxicol. 2009, 49:303-326.
14. Jordan R. Potyviruses, monoclonal antibodies, and antigenic sites. Arch. Virol. Suppl. 1992, 5:81-95.
15. Jordan R., Hammond J. Comparison and differentiation of potyvirus isolates and identification of strain-, virus-, subgroup-specific and potyvirus group-common epitopes using monoclonal antibodies. J. Gen. Virol. 1991, 72:25-36.
16. Kaumaya P.T.P., Foy K.C. Peptide vaccines and peptidomimetics targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapy. Future Oncol. 2012, 8:961-987.
17. Kendall A., McDonald M., Bian W., Bowles T., Baumgarten S.C., Shi J., Stewart P.L., Bullitt E., Gore D., Irving T.C., Havens W.M., Ghabrial S.A., Wall J.S., Stubbs G. Structure of flexible filamentous plant viruses. J. Virol. 2008, 82:9546-9554.
18. Kimalov B., Gal-On A., Stav R., Belausov E., Arazi T. Maintenance of coat protein N-terminal net charge and not primary sequence is essential for zucchini yellow mosaic virus systemic infectivity. J. Gen. Virol. 2004, 85:3421-3430.
19. Kumar S., Ochoa W., Singh P., Hsu C., Schneemann A., Manchester M., Olson M., Reddy V. Tomato bushy stunt virus (TBSV), a versatile platform for polyvalent display of antigenic epitopes and vaccine design. Virology 2009, 388:185-190.
20. Larman H.B., Zhao Z., Laserson U., Li M.Z., Ciccia A., Gakidis M.A., Church G.M., Kesari S., Leproust E.M., Solimini N.L., Elledge S.J. Autoantigen discovery with a synthetic human peptidome. Nat. Biotechnol. 2011, 29:535-541.
21. Li L., Wu J., Gao C. Gradient immobilization of a cell adhesion RGD peptide on thermal responsive surface for regulating cell adhesion and detachment. Colloids Surf. B Biointerfaces 2011, 85:12-18.
22. López-Moya J.J., Pirone T.P. Charge changes near the N terminus of the coat protein of two potyviruses affect virus movement. J. Gen. Virol. 1998, 79:161-165.
23. McCormick A.A., Palmer K.E. Genetically engineered Tobacco mosaic virus as nanoparticle vaccines. Expert Rev. Vaccines 2008, 7:33-41.
24. Mellor R.H., Hubert C.E., Stanton A.W., Tate N., Akhras V., Smith A., Burnand K.G., Jeffery S., Makinen T., Levick J.R., Mortimer P.S. Lymphatic dysfunction, not aplasia, underlies Milroy disease. Microcirculation 2010, 17:281-296.
25. Milne R.G., Luisoni E. Rapid immune electron microscopy of virus preparations. Methods in Virology 1977, 265-281. Academic Press, New York. K. Maramorosch, H. Koprowski (Eds.).
26. Moyle P.M., Olive C., Good M.F., Toth I. Method for the synthesis of highly pure vaccines using the lipid core peptide system. J. Pept. Sci. 2006, 12:800-807.
27. Palmieri G., Cassani G., Fassina G. Peptide immobilization on calcium alginate beads: applications to antibody purification and assay. J. Chromatogr. B 1995, 664:127-135.
28. Sabatino G., Papini A.M. Advances in automatic, manual and microwave-assisted solid-phase peptide synthesis. Curr. Opin. Drug Discov. Dev. 2008, 11:762-770.
29. Saenz L., Neira-Carrillo A., Paredes R., Cortes M., Bucarey S., Arias J.L. Chitosan formulations improve the immunogenicity of a GnRH-I peptide-based vaccine. Int. J. Pharm. 2009, 369:64-71.
30. Sánchez F., Martínez-Herrera D., Aguilar I., Ponz F. Infectivity of turnip mosaic potyvirus cDNA clones and transcripts on the systemic host Arabidopsis thaliana and local lesion hosts. Virus Res. 1998, 55:207-219.
31. Sánchez F., Wang X., Jenner C.E., Walsh J.A., Ponz F. Strains of Turnip mosaic potyvirus as defined by the molecular analysis of the coat protein gene of the virus. Virus Res. 2003, 94:33-43.
32. Seo J., Pyo H., Lee S., Lee J., Kim T. Expression of 4 truncated fragments of Pasteurella multocida toxin and their immunogenicity. Can. J. Vet. Res. 2009, 73:184-189.
33. Shinnick T.M., Sutcliffe J.G., Green N., Lerner R.A. Peptide-elicited protein-reactive antibodies in molecular biology and medicine. J. Investig. Dermatol. 1984, 83:112s-115s.
34. Spence N.J. The identification, distribution and ecology of bean common mosaic virus in Africa 1992, University of Birmingham, UK, (PhD Thesis).
35. Steinmetz N.F., Lin T., Lomonossoff G.P., Johnson J.E. Structure-based engineering of an icosahedral virus for nanomedicine and nanotechnology. Curr. Top. Microbiol. Immunol. 2009, 327:23-58.
36. Steinmetz N.F., Mertens M.E., Taurog R.E., Johnson J.E., Commandeur U., Fischer R., Manchester M. Potato virus X as a novel platform for potential biomedical applications. Nano Lett. 2009, 10:305-312.
37. Tammela T., Zarkada G., Wallgard E., Murtomaki A., Suchting S., Wirzenius M., Waltari M., Hellstrom M., Schomber T., Peltonen R., Freitas C., Duarte A., Isoniemi H., Laakkonen P., Christofori G., Yla-Herttuala S., Shibuya M., Pytowski B., Eichmann A., Betsholtz C., Alitalo K. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 2008, 454:656-660.
38. Touriño A., Sánchez F., Fereres A., Ponz F. High expression of foreign proteins from a biosafe viral vector derived from Turnip mosaic virus. Span. J. Agric. Res. 2008, 6:48-58.
39. van Iterson V., Leidenius M., von Smitten K., Bono P., Heikkila P. VEGF-D in association with VEGFR-3 promotes nodal metastasis in human invasive lobular breast cancer. Am. J. Clin. Pathol. 2007, 128:759-766.
40. Villa C.H., Dao T., Ahearn I., Fehrenbacher N., Casey E., Rey D.A., Korontsvit T., Zakhaleva V., Batt C.A., Philips M.R., Scheinberg D.A. Single-walled carbon nanotubes deliver peptide antigen into dendritic cells and enhance IgG responses to tumor-associated antigens. ACS Nano 2011, 5:5300-5311.
41. Voskens C.J., Strome S.E., Sewell D.A. Synthetic peptide-based cancer vaccines: lessons learned and hurdles to overcome. Curr. Mol. Med. 2009, 9:683-693.
42. Wraith D.C. Therapeutic peptide vaccines for treatment of autoimmune diseases. Immunol. Lett. 2009, 122:134-136.
43. Yokoo N., Togashi T., Umetsu M., Tsumoto K., Hattori T., Nakanishi T., Ohara S., Takami S., Naka T., Abe H., Kumagai I., Adschiri T. Direct and selective immobilization of proteins by means of an inorganic material-binding peptide: discussion on functionalization in the elongation to material-binding peptide. J. Phys. Chem. B 2010, 114:480-486.